TABLE S1: Pharmacological treatment at follow-up assessment

ECT group / Pharmacological
Treatment:
drug and dose(mg/day) / Non-ECT group / Pharmacological
Treatment:
drug and dose(mg/day)
1 / Clozapine 350
Aripiprazole 10
Clorimipramine 75 / 1 / Clozapine 200
Aripiprazole 10
2 / Clozapine 150 / 2 / Olanzapine 30
3 / Clozapine 350
Aripiprazole 5
Valproic acid 1000
Lithium 800 / 3 / Aripiprazole 20
4 / None / 4 / Intramuscular paliperidone palmitate 50
Olanzapine 5
5 / Clozapine 150
Aripiprazole 20
Fluvoxamine 150 / 5 / Risperidone 1
6 / Levomepromazine 50 / 6 / Paliperidone 3
Intramuscular Fluphenazine decanoate 25mg/15days
Sertraline 100
7 / Clozapine 225 / 7 / Risperidone 7
Fluoxetine 20
8 / Clozapine 500
Aripiprazole 10
Topiramate 200 / 8 / Risperidone 3
Lithium 1200
9 / Clozapine 350
Valproic acid 1000 / 9 / Clozapine 200
Citalopram 20
10 / Risperidone 5
Aripiprazole 15
Clorimipramine 150 / 10 / Quetiapine 750
11 / Clozapine 300
Paliperidone 18 / 11 / Clozapine 100
Citalopram 30
12 / Olanzapine 2.5
Paliperidone 3
Escitalopram 10 / 12 / Aripiprazole 10
Lithium 800
13 / Clozapine 450
Aripiprazole 5
Levomepromazine100
Trazodone 100
Sertraline 50 / 13 / Risperidone 4
Fluvoxamine 250
14 / None / 14 / Olanzapine 10
Lithium 800
15 / Clozapine 250
Lithium 1000 / 15 / Clozapine 300
Aripiprazole 7.5
Citalopram 20
16 / Clozapine 200
Periciazine 60 / 16 / Clozapine 275
Lithium 1200
17 / Haloperidol 15
Clorpromazine 100 / 17 / Clozapine 250
18 / Clozapine 300
Perphenazine 2.5 / 18 / Clozapine350
Sertraline
Topiramate
19 / Clozapine 50
Long-acting Risperidone 37.5
Valproic acid / 19 / Risperidone 3
Aripiprazole 5
Lithium 1000
20 / Clozapine 400 / 20 / Risperidone 1.5
Aripiprazole 5
21 / Risperidone 6
Valproic acid 1000 / 21 / Quetiapine 300
Fluoxetine 20

Table S2. Comparison of clinical variables in catatonic and treatment-resistant patients in the ECT group.(ONLINE SUPPLEMENT)

BASELINE
CLINICAL VARIABLES / Catatonia (n=4)
(mean ± SD) / Treatment-resistant patients (n=17)
(mean ± SD) / Za / p value
CGI
GAF
PANSS Total
PANSS Positive
PANSS Negative
PANSS General / 7±0.0
7.5±2.88
86.00±18.11
20.00±9.09
20.50±8.88
45.50±9.25 / 7±0.0
16.64±4.75
80.65±13.29
22.53±5.08
19.24±7.45
38.88±7.07 / 0.0
-2.88
-1.07
-0.67
-0.45
-1.34 / 1.000
0.002
0.317
0.517
0.698
0.203
CLINICAL VARIABLES AT FOLLOW-UP / Catatonia (n=4)
(mean ± SD) / Treatment-resistant patients (n=17)
(mean ± SD) / Za / p value
CGI
GAF
PANSS Total
PANSS Positive
PANSS Negative
PANSS General / 2.25±1.5
65±14.14
44.50±17.25
9.25±3.86
14.50±10.66
20.75±3.30 / 3.41±0.79
54±8.08
55.88±9.96
11.35±2.54
17.18±5.19
27.35±4.41 / -1.46
-1.69
-1.57
-1.09
-1.21
-2.33 / 0.203
0.099
0.120
0.317
0.237
0.018

a Mann-Whitney U test

SD=Standard Deviation

PANSS = Positive and Negative Syndrome Scale

CGI = Clinical Global Impression-Improvement scale